Group 1 - The company will not distribute cash dividends, issue bonus shares, or convert reserves into share capital for the reporting period [2] - The company approved a stock repurchase loan application of RMB 44.5 million from Bank of Communications Shaanxi Branch on April 8, 2025 [7] - The company increased its investment in Xi'an International Medical Center by RMB 380 million, raising its registered capital from RMB 1.4 billion to RMB 1.78 billion [7] Group 2 - The company held its 13th Board of Directors' sixth meeting on August 20, 2025, with all seven directors present [8] - The board approved the 2025 semi-annual report and its summary with unanimous consent [9] - The board proposed amendments to the company's articles of association and various governance rules, which require shareholder approval [10][12] Group 3 - The company announced the resignation of several board members due to governance structure adjustments following the revision of the Company Law [26] - The resigning members will continue to hold other positions within the company [27] - The company expressed gratitude for the contributions of the departing members during their tenure [28] Group 4 - The company will hold its first extraordinary general meeting of 2025 on September 8, 2025, at 2:45 PM [30][31] - Shareholders can participate in the meeting through both on-site voting and online voting [33] - The deadline for shareholder registration is September 3, 2025 [34]
西安国际医学投资股份有限公司2025年半年度报告摘要